Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

Janjigian, Yelena Y., Al-Batran, Salah-Eddin, Wainberg, Zen A., Van Cutsem, Eric, Molena, Daniela, Muro, Kei, Hyung, Woo Jin, Wyrwicz, Lucjan, Oh, Do-Youn, Omori, Takeshi, Moehler, Markus, Garrido, Marcelo, Oliveira, Sulene C. S., Liberman, Moishe, Oliden, Victor C., Bilici, Mehmet, Kurland, John, Xynos, Ioannis, Mann, Helan, Tabernero, Josep